Layn Natural Ingredients Acquires $1.5 Million in Ispire's Initial Public Offering

Market by Shenzhen Stock Exchange; Rui Tian

Apr.11.2023

CBD manufacturer Ispire is listed on the NASDAQ stock exchange in the US, with an issue price of $7.00. Layn Natural Ingredients purchased 214,285 shares of Ispire's public offering using its own funds, totaling $1.5 million.

On April 4th, CBD manufacturer Ispire went public on the NASDAQ stock exchange in the United States, issuing 2.7 million common shares at a price of $7.00 per share.

Layn Natural Ingredients is a domestic plant extraction industry enterprise mainly engaged in the research, production, and sales of plant standardization extraction and high-purity active monomers.

Nebulization products are an important downstream application field of industrial cannabis. According to Frost Sullivan's research data, from 2018 to 2022, the global market size of electronic nebulization devices has an annual growth rate of 18.1%, and it is expected to maintain a growth rate of around 18.5% from 2022 to 2027.

Layn Natural Ingredients obtained Ispire's first public offering shares allocation with its own funds

On April 7th, Layn Natural Ingredients announced that it used its own funds of $1,499,995 to obtain an allocation of 214,285 shares of Ispire (stock abbreviation "ISPR") in its first public offering on the NASDAQ at a price of $7.00 per share. The shares offered in this IPO were listed on the NASDAQ on April 4, 2023 (local time in the United States).

It is beneficial for cooperation in the cannabis field

Layn Natural Ingredients stated that its participation in Ispire's IPO strategic placement is to promote deeper cooperation between the two parties in the industrial cannabis business, combining their respective sales channels and other resources to achieve win-win cooperation.

Ispire closed at $7.55 on the first day of its listing, an increase of 7.86%, with a market value of $400 million. As of now, the latest stock price is $7.00, and the latest market value is $368.7 million.

Also read:

[1] CBD manufacturer Ispire completes its first public offering, raising $18.9 million

[2] CBD manufacturer Ispire announces the pricing of its first public offering: $7 per share, issuing 2.7 million shares

Reference:

[1] Layn Natural Ingredients: Announcement on Obtaining Ispire's First Public Offering Shares Allocation and Listing

#Europe #Disposable e-cigarettes #Regulation #Russia #Ispire Technologies Inc.

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it.

Glas, the FDA, and the Future of Flavored ENDS

Glas, the FDA, and the Future of Flavored ENDS

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns

U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns

A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”

At a policy forum hosted by The Hill and sponsored by PMI US, U.S. defense health officials, lawmakers and industry representatives discussed tobacco use in the military and explored the potential role of smoke-free nicotine products — including e-cigarettes and nicotine pouches — as transitional tools to help service members reduce reliance on combustible cigarettes.

Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%

Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%

Casey’s General Stores (NASDAQ: CASY) reported accelerating growth in modern nicotine products during its fiscal third quarter ended January 31, 2026. Nicotine pouch sales increased 31% year over year, while vapor products rose 12%. Although cigarette unit sales continued to decline, management stated that the rate of decline slowed compared to prior quarters.

Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market

Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market

According to a LinkedIn post published by Sesh CMO Josh Metz on February 25, 2026, Sesh Products has introduced a 200-pouch nicotine pouch refill bag sold with a reusable metal can. In a U.S. MO market dominated by 20-pouch plastic cans, the product offers a larger retail unit size. The company lists a standard price of USD 49.99, with a uniform 15% discount currently applied, bringing the price to USD 42.49.

Special Report｜Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain

Special Report｜Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain

The U.S. International Trade Commission (ITC) has terminated Investigation 337-TA-1410 after invalidating key vape patent claims asserted by R.J. Reynolds Vapor Company, removing the immediate risk of import bans for dozens of companies. However, a new case—337-TA-1486—has already opened a more consequential legal front, shifting the focus from patent disputes to regulatory compliance across the vape supply chain, including PACT Act reporting, tax compliance, and FDA marketing authorization.

Related Topics

Related Read

U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns

U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”

U.S. Military Smoking Debate Spotlights E-Cigarettes and Nicotine Pouches as a “Bridge”

Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%

Casey’s, the No. 3 U.S. C-Store Chain, Sees Nicotine Category Shift as Pouches Rise 31% and Vapor 12%

Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market

Sesh Launches 200-Pouch Refill Bag, Expanding Retail Unit Size in U.S. Nicotine Pouch Market

Special Report｜Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain

Special Report｜Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain